Over 90% of all cancer mortalities result from spreading or recurrence, called metastases. Yet, for most cancer types, treatments are ineffective against metastatic cancer cells. Our product, a proprietary "smart" anti-cancer cellular therapeutic, called Mesenkillers™ (MSK) is designed to halt the metastatic process. MSK are engineered stem cells that innately target the tumor bed, confront the specific cancer cells scientists have shown are responsible for metastases, and will only deploy their active molecule when signaled by these cancer cells.